Figure 5C illustrates that SOX2 expression was significantly decreased upon treatment with YM-58483 in all GBM cells tested and with GSK-7975A in 2 of 3 GBM cells tested, confirming a role of SOC in the maintenance or expansion of GSC. Here, UBXN11 is linked to glioblastoma.